Cell Therapy Biomanufacturing Market Size, Share, By Product Type (Consumables, Equipment, Systems & Software), Cell Type (T-cell, Stem Cell, and Others), Process (Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control, and Others), End User (Biopharmaceutical Biotechnology Companies, Research Institutes, Cell Banks, and Others), and Region - Trends, Analysis, and Forecast till 2035

Among the leading companies in the cell therapy biomanufacturing market are Bio-Techne, Repligen Corporation, Lonza, Merck KGaA, and Sartorius AG. Businesses involved in cell therapy biomanufacturing will need to make significant investments in automation and state-of-the-art technologies to boost scalability, reduce costs, and ensure consistency. Businesses will prioritize strengthening supply chains, increasing production capacity, and researching off-the-shelf allogeneic medications in order to meet the growing market demand.

List of Key Players in the Market:

• Sartorius AG
• Merck KGaA
• Corning Incorporated
•  Miltenyi Biotec
•  Repligen Corporation
•  Bio-Techne.
• Eppendorf SE
• PBS Biotech, Inc.
• Lonza
•  BD
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.

Recent News:

• In order to streamline gene delivery solutions for the creation and production of cutting-edge cell therapies, Kytopen Corp., a pioneer in continuous flow cellular engineering technologies, and Bio-Techne Corporation, a pioneer in cutting-edge life science research instruments, announced a partnership on May 2025. Through the use of the Flowfect Tx GMP cellular engineering platform and the TcBuster GMP non-viral genome engineering system, the cooperation will concentrate on the synergies that developers may get.